Compare AVXL & SRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AVXL | SRTA |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 430.9M | 472.4M |
| IPO Year | 2013 | N/A |
| Metric | AVXL | SRTA |
|---|---|---|
| Price | $4.19 | $4.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $22.00 | $7.63 |
| AVG Volume (30 Days) | ★ 826.5K | 774.7K |
| Earning Date | 02-09-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $37.89 |
| Revenue Next Year | N/A | $14.33 |
| P/E Ratio | ★ N/A | $9.88 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.86 | $3.85 |
| 52 Week High | $13.99 | $6.02 |
| Indicator | AVXL | SRTA |
|---|---|---|
| Relative Strength Index (RSI) | 39.48 | 42.71 |
| Support Level | $3.60 | $4.11 |
| Resistance Level | $5.27 | $5.46 |
| Average True Range (ATR) | 0.27 | 0.24 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 11.20 | 23.08 |
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. Its core services include air and ground logistics, surgical organ recovery, organ placement, and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.